FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091571 [Registered on: 24/07/2025] Trial Registered Prospectively
Last Modified On: 04/08/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   case control and cohort study 
Study Design  Other 
Public Title of Study   "Creating prediction tools to help understand and manage patients with mouth cancer risks and outcomes"  
Scientific Title of Study   Development and Validation of Predictive Nomograms for Clinical Application in Oral Squamous cell carcinoma  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vasantha MN 
Designation  PhD Scholar 
Affiliation  Kasturba Medical College, Manipal 
Address  Dept of Head and Neck Surgery, Kasturba Medical College, MAHE, Manipal

Udupi
KARNATAKA
576104
India 
Phone  7899650659  
Fax    
Email  vasantha.kmcmpl2024@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Devaraja K 
Designation  Associate Professor 
Affiliation  Kasturba Medical College and Hospital, Manipal 
Address  Dept of Head and Neck Surgery, Kasturba Medical College, MAHE, Manipal

Udupi
KARNATAKA
576104
India 
Phone  9999662597  
Fax    
Email  devaraja.k@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Vasantha MN 
Designation  PhD Scholar 
Affiliation  Kasturba Medical College, Manipal 
Address  Dept of Head and Neck Surgery, Kasturba Medical College, MAHE, Manipal

Udupi
KARNATAKA
576104
India 
Phone  7899650659  
Fax    
Email  vasantha.kmcmpl2024@learner.manipal.edu  
 
Source of Monetary or Material Support  
Kasturba Medical College and Hospital,Dept of Head and Neck Surgery, Kasturba Medical College, MAHE, MAnipal-576104, Udupi, Karnataka, India. 
 
Primary Sponsor  
Name  Kasturba Medical College 
Address  Dept of Head and Neck Surgery, Kasturba Medical College, MAHE, MAnipal-576104, Udupi, Karnataka, India. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vasantha MN  Dept of Head and Neck Surgery  Kasturba Medical College, MAHE,Manipal
Udupi
KARNATAKA 
7899650659

vasantha.kmcmpl2024@learner.manipal.edu 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical college, Kasturba Hospital, Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C020||Malignant neoplasm of dorsal surface of tongue, (2) ICD-10 Condition: C030||Malignant neoplasm of upper gum, (3) ICD-10 Condition: C031||Malignant neoplasm of lower gum, (4) ICD-10 Condition: C039||Malignant neoplasm of gum, unspecified, (5) ICD-10 Condition: C040||Malignant neoplasm of anterior floor of mouth, (6) ICD-10 Condition: C041||Malignant neoplasm of lateral floor of mouth, (7) ICD-10 Condition: C048||Malignant neoplasm of overlappingsites of floor of mouth, (8) ICD-10 Condition: C049||Malignant neoplasm of floor of mouth, unspecified, (9) ICD-10 Condition: C050||Malignant neoplasm of hard palate, (10) ICD-10 Condition: C058||Malignant neoplasm of overlappingsites of palate, (11) ICD-10 Condition: C059||Malignant neoplasm of palate, unspecified, (12) ICD-10 Condition: C148||Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx, (13) ICD-10 Condition: C062||Malignant neoplasm of retromolar area,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1)Biopsy proven cancers involving oral cavity (ICD 10- C02, C03, C04, C05, C06)
2)Any T(T1-4) and any N(N1-3), with M0 (non-metastatic)
3) Undergone curative intent treatment at Kasturba Hospital, Manipal
4)Controls (for objective 1): Age and gender matched healthy subjects 
 
ExclusionCriteria 
Details  1)Multiple primary cancers
2)Recurrent cancers
3)Incomplete medical re 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
All-cause mortality  2 years and 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="526"
Sample Size from India="526" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
This study is a prospective longitudinal study. The primary aim of our study is to develop and validate Nomograms for predicting 1) Carcinogenesis 2) lymph node metastasis and 3) survival outcomes using demographic data, clinical variables, pathological characteristics, as well as nutritional and inflammatory markers, as applicable. 
Close